10 Pre-clinical studies of sotagliflozin in hypertrophic cardiomyopathy
OBJECTIVES/GOALS: Study the regulatory role of sodium glucose co-transporter 1 (SGLT1) in cardiomyocytes and the therapeutic potential of sotagliflozin in hypertrophic cardiomyopathy (HCM) by (a) quantifying SGLT1 expression in HCM and (b) examining the impact of sotagliflozin on cardiac mechanics....
| Autori principali: | , , , |
|---|---|
| Natura: | Articolo |
| Lingua: | English |
| Pubblicazione: |
Cambridge University Press
2024-04-01
|
| Serie: | Journal of Clinical and Translational Science |
| Accesso online: | https://www.cambridge.org/core/product/identifier/S2059866124000311/type/journal_article |